The relationship between BMI and glycaemic control after monotherapy with metformin XR in Chinese patients with type 2 diabetes mellitus

Efficacy of metformin on glycemic control and weight in drug-naive type 2 diabetes mellitus patients: A systematic review and meta-analysis of placebo-controlled randomized trials

Piera-Mardemootoo, Carole
Lambert, Philippe
Faillie, Jean-Luc

January 2021

International audienceAIM OF THE STUDY: Metformin is recommended as the first-line treatment of type...

The Effects of Combined Insulin and Metformin Therapy in Obese Patients with Diabetes Mellits Type 2 in the Early Stage of the Disease

Belma Aščić - Buturović

May 2006

Combination of insulin and metformin has been shown to improve glycaemic control in clinical trials,...

Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin

Derosa G
Carbone A
Franzetti I
Querci F
Fogari E
Bianchi L
Bonaventura A
Romano D
Maffioli P.
CICERO, ARRIGO FRANCESCO GIUSEPPE

January 2012

Aims: To evaluate the impact on glycemic control, insulin resistance, and insulin secretion of sitag...

Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial.

Linong Ji
Hongmei Li
Xiaohui Guo
Yan Li
Renming Hu
Zhengying Zhu

Differences exist between treatment recommendations regarding the choice of metformin as first-line ...

Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial,” PLoS

Linong Ji
Hongmei Li
Xiaohui Guo
Yan Li
Renming Hu
Zhengying Zhu

January 2013

Background: Differences exist between treatment recommendations regarding the choice of metformin as...

Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial

Ji, Linong
Li, Hongmei
Guo, Xiaohui
Li, Yan
Hu, Renming
Zhu, Zhengying

January 2013

Background: Differences exist between treatment recommendations regarding the choice of metformin as...

The magnitude of weight loss induced by metformin is independently associated with BMI at baseline in newly diagnosed type 2 diabetes: Post-hoc analysis from data of a phase IV open-labeled trial

Zhou, Lingli
Cai, Xiaoling
Yang, Wenjia
Han, Xueyao
Ji, Linong

January 2017

Background. The impact of metformin on body weight is variable in T2DM patients among studies. The r...

Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients

Guo Lixin
Guo Xiaohui
Li Yan
Hong Xu
Jiang Xiaozhen
Su Qing
Zhao Dong
Wu Xiaojing
Ji Linong

January 2016

To determine whether gastrointestinal (GI) tolerability of metformin monotherapy varies according to...

The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes

Donnelly, L. A.
Doney, A. S. F.
Hattersley, A. T.
Morris, A. D.
Pearson, E. R.

February 2006

Aims: In treating Type 2 diabetes (T2DM), UK guidelines recommend metformin in obese and overweight ...

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment

Tatiana Ivanovna Romantsova
T Sh Dzhavakhishvili
O V Roik

March 2013

Aims. To study the dynamics of body weight, waist circumference, blood lipid and insulin demand in...

The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study

Gao, H.
Xiao, W.
Wang, C.
Zhang, J.
Yang, Y.
Yang, J.
Yang, W.
Hong, T.

January 2008

Aim: To investigate the effects of extended-release metformin (MXR) compared with immediate-release ...

INTRODUCTION Effectiveness of metformin and lifestyle interventions as an initial treatment in Japanese patients with newly diagnosed type 2 diabetes : a prospective observational study

Satoru Sumitani
Shinya Morita
Yoshihiko Utsu
Kosuke Mukai
Shunji Miki
Bunzo Sato
Hideji Nakamura
Soji Kasayama

April 2020

Optimal control of hyperglycemia and associated risk factors reduces the risk of diabetes-related co...

Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, \u3b2-cell function and insulin resistance in type 2 diabetic patients

Derosa, Giuseppe
Carbone, Anna
Franzetti, Ivano
Querci, Fabrizio
Fogari, Elena
Bianchi, Lucio
Bonaventura, Aldo
Romano, Davide
Cicero, Arrigo F. G.
Maffioli, Pamela

January 2012

Aims: To evaluate the impact on glycemic control, insulin resistance, and insulin secretion of sitag...

A QUASI-EXPERIMENTAL STUDY TO EXAMINE THE ACTION STATISTICS OF METFORMIN IN TYPE II DIABETES MELLITUS PATIENTS

M.Shamim ul Husnain, Sh. Sarmad Elahi, Zulqarnain Haider

June 2019

Aim of Study: The main purpose of our study was to judge the action statistics of metformin in type ...

The effect of metformin on fasting and postprandial insulin secretion in obese patients with diabetes mellitus type 2

Vuković Mira
Lapčević Mirjana
Kalezić Nevena
Gvozdenović Branislav S.

January 2007

Introduction The main causes of reduced glucose levels during metformin therapy appear to be an incr...

Efficacy of metformin on glycemic control and weight in drug-naive type 2 diabetes mellitus patients: A systematic review and meta-analysis of placebo-controlled randomized trials

Piera-Mardemootoo, Carole
Lambert, Philippe
Faillie, Jean-Luc

January 2021

International audienceAIM OF THE STUDY: Metformin is recommended as the first-line treatment of type...

The Effects of Combined Insulin and Metformin Therapy in Obese Patients with Diabetes Mellits Type 2 in the Early Stage of the Disease

Belma Aščić - Buturović

May 2006

Combination of insulin and metformin has been shown to improve glycaemic control in clinical trials,...

Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin

Derosa G
Carbone A
Franzetti I
Querci F
Fogari E
Bianchi L
Bonaventura A
Romano D
Maffioli P.
CICERO, ARRIGO FRANCESCO GIUSEPPE

January 2012

Aims: To evaluate the impact on glycemic control, insulin resistance, and insulin secretion of sitag...

Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial.

Linong Ji
Hongmei Li
Xiaohui Guo
Yan Li
Renming Hu
Zhengying Zhu

Differences exist between treatment recommendations regarding the choice of metformin as first-line ...

Impact of baseline BMI on glycemic control and weight change with metformin monotherapy in Chinese type 2 diabetes patients: phase IV open-label trial,” PLoS

Linong Ji
Hongmei Li
Xiaohui Guo
Yan Li
Renming Hu
Zhengying Zhu

January 2013

Background: Differences exist between treatment recommendations regarding the choice of metformin as...

Impact of Baseline BMI on Glycemic Control and Weight Change with Metformin Monotherapy in Chinese Type 2 Diabetes Patients: Phase IV Open-Label Trial

Ji, Linong
Li, Hongmei
Guo, Xiaohui
Li, Yan
Hu, Renming
Zhu, Zhengying

January 2013

Background: Differences exist between treatment recommendations regarding the choice of metformin as...

The magnitude of weight loss induced by metformin is independently associated with BMI at baseline in newly diagnosed type 2 diabetes: Post-hoc analysis from data of a phase IV open-labeled trial

Zhou, Lingli
Cai, Xiaoling
Yang, Wenjia
Han, Xueyao
Ji, Linong

January 2017

Background. The impact of metformin on body weight is variable in T2DM patients among studies. The r...

Effects of body mass index or dosage on gastrointestinal disorders associated with extended-release metformin in type 2 diabetes: Sub-analysis of a Phase IV open-label trial in Chinese patients

Guo Lixin
Guo Xiaohui
Li Yan
Hong Xu
Jiang Xiaozhen
Su Qing
Zhao Dong
Wu Xiaojing
Ji Linong

January 2016

To determine whether gastrointestinal (GI) tolerability of metformin monotherapy varies according to...

The effect of obesity on glycaemic response to metformin or sulphonylureas in Type 2 diabetes

Donnelly, L. A.
Doney, A. S. F.
Hattersley, A. T.
Morris, A. D.
Pearson, E. R.

February 2006

Aims: In treating Type 2 diabetes (T2DM), UK guidelines recommend metformin in obese and overweight ...

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment

Tatiana Ivanovna Romantsova
T Sh Dzhavakhishvili
O V Roik

March 2013

Aims. To study the dynamics of body weight, waist circumference, blood lipid and insulin demand in...

The metabolic effects of once daily extended-release metformin in patients with type 2 diabetes: a multicentre study

Gao, H.
Xiao, W.
Wang, C.
Zhang, J.
Yang, Y.
Yang, J.
Yang, W.
Hong, T.

January 2008

Aim: To investigate the effects of extended-release metformin (MXR) compared with immediate-release ...

INTRODUCTION Effectiveness of metformin and lifestyle interventions as an initial treatment in Japanese patients with newly diagnosed type 2 diabetes : a prospective observational study

Satoru Sumitani
Shinya Morita
Yoshihiko Utsu
Kosuke Mukai
Shunji Miki
Bunzo Sato
Hideji Nakamura
Soji Kasayama

April 2020

Optimal control of hyperglycemia and associated risk factors reduces the risk of diabetes-related co...

Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, \u3b2-cell function and insulin resistance in type 2 diabetic patients

Derosa, Giuseppe
Carbone, Anna
Franzetti, Ivano
Querci, Fabrizio
Fogari, Elena
Bianchi, Lucio
Bonaventura, Aldo
Romano, Davide
Cicero, Arrigo F. G.
Maffioli, Pamela

January 2012

Aims: To evaluate the impact on glycemic control, insulin resistance, and insulin secretion of sitag...

A QUASI-EXPERIMENTAL STUDY TO EXAMINE THE ACTION STATISTICS OF METFORMIN IN TYPE II DIABETES MELLITUS PATIENTS

M.Shamim ul Husnain, Sh. Sarmad Elahi, Zulqarnain Haider

June 2019

Aim of Study: The main purpose of our study was to judge the action statistics of metformin in type ...

The effect of metformin on fasting and postprandial insulin secretion in obese patients with diabetes mellitus type 2

Vuković Mira
Lapčević Mirjana
Kalezić Nevena
Gvozdenović Branislav S.

January 2007

Introduction The main causes of reduced glucose levels during metformin therapy appear to be an incr...

Efficacy of metformin on glycemic control and weight in drug-naive type 2 diabetes mellitus patients: A systematic review and meta-analysis of placebo-controlled randomized trials

Piera-Mardemootoo, Carole
Lambert, Philippe
Faillie, Jean-Luc

January 2021

International audienceAIM OF THE STUDY: Metformin is recommended as the first-line treatment of type...

The Effects of Combined Insulin and Metformin Therapy in Obese Patients with Diabetes Mellits Type 2 in the Early Stage of the Disease

Belma Aščić - Buturović

May 2006

Combination of insulin and metformin has been shown to improve glycaemic control in clinical trials,...

Effects of a combination of sitagliptin plus metformin vs metformin monotherapy on glycemic control, β-cell function and insulin

Derosa G
Carbone A
Franzetti I
Querci F
Fogari E
Bianchi L
Bonaventura A
Romano D
Maffioli P.
CICERO, ARRIGO FRANCESCO GIUSEPPE

January 2012

Aims: To evaluate the impact on glycemic control, insulin resistance, and insulin secretion of sitag...

The relationship between BMI and glycaemic control after monotherapy with metformin XR in Chinese patients with type 2 diabetes mellitus

Abstract

Extracted data

The relationship between BMI and glycaemic control after monotherapy with metformin XR in Chinese patients with type 2 diabetes mellitus

Abstract

Extracted data

Related items

Related items